Vivitrol (Naltrexone) vs Suboxone (Buprenorphine): Side-by-Side Comparison (2026)

Key Differences Explained

Vivitrol and Suboxone are both FDA-approved for opioid use disorder but work through completely opposite mechanisms. Understanding this difference is critical for choosing the right medication.

Vivitrol (extended-release naltrexone) is an opioid antagonist — it blocks opioid receptors entirely. If you use opioids while on Vivitrol, you won't feel any effect. It's given as a monthly injection, eliminating daily adherence concerns. The catch: you must complete detox first (7-14 days opioid-free) before starting, which is the biggest barrier to initiation.

Suboxone (buprenorphine/naloxone) is a partial opioid agonist — it partially activates opioid receptors, enough to prevent withdrawal and reduce cravings but not enough to produce a "high." It can be started during withdrawal (no detox completion needed), making it immediately accessible. Available as daily sublingual film or tablet.

What the Research Says

The landmark X:BOT trial (Lancet, 2018) compared both head-to-head. Once initiated, both showed equal effectiveness in reducing opioid use. However, more patients successfully started Suboxone (72%) than Vivitrol (42%) because of the detox requirement. This makes Suboxone the first-line choice for patients who can't safely complete detox or need immediate stabilization.

Vivitrol has a unique advantage for alcohol use disorder — it's FDA-approved for both opioid and alcohol addiction, reducing heavy drinking days by 25%. It's also preferred in criminal justice settings due to zero diversion risk. Compare with disulfiram (Antabuse) for alcohol-specific options.